1. Home
  2. ABP vs SST Comparison

ABP vs SST Comparison

Compare ABP & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • SST
  • Stock Information
  • Founded
  • ABP 2004
  • SST 2013
  • Country
  • ABP United States
  • SST United States
  • Employees
  • ABP N/A
  • SST N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • SST Diversified Commercial Services
  • Sector
  • ABP Health Care
  • SST Consumer Discretionary
  • Exchange
  • ABP Nasdaq
  • SST Nasdaq
  • Market Cap
  • ABP 78.8M
  • SST 67.8M
  • IPO Year
  • ABP N/A
  • SST N/A
  • Fundamental
  • Price
  • ABP $1.10
  • SST $0.93
  • Analyst Decision
  • ABP
  • SST Hold
  • Analyst Count
  • ABP 0
  • SST 1
  • Target Price
  • ABP N/A
  • SST $2.00
  • AVG Volume (30 Days)
  • ABP 47.0K
  • SST 95.5K
  • Earning Date
  • ABP 04-03-2025
  • SST 11-07-2024
  • Dividend Yield
  • ABP N/A
  • SST N/A
  • EPS Growth
  • ABP N/A
  • SST N/A
  • EPS
  • ABP N/A
  • SST N/A
  • Revenue
  • ABP $122,000.00
  • SST $364,450,000.00
  • Revenue This Year
  • ABP N/A
  • SST N/A
  • Revenue Next Year
  • ABP N/A
  • SST $15.56
  • P/E Ratio
  • ABP N/A
  • SST N/A
  • Revenue Growth
  • ABP N/A
  • SST N/A
  • 52 Week Low
  • ABP $1.09
  • SST $0.82
  • 52 Week High
  • ABP $13.00
  • SST $3.02
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • SST 43.80
  • Support Level
  • ABP N/A
  • SST $0.82
  • Resistance Level
  • ABP N/A
  • SST $1.08
  • Average True Range (ATR)
  • ABP 0.00
  • SST 0.08
  • MACD
  • ABP 0.00
  • SST -0.00
  • Stochastic Oscillator
  • ABP 0.00
  • SST 40.38

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About SST System1 Inc.

System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.

Share on Social Networks: